Tetrous earned a U.S. patent related to its EnFix family of demineralized cortical bone fiber implants, according to a Jan. 13 news release.
The new patent protects the application of EnFix DBF technology for enthesis reformation. The platform leverages a proprietary form of demineralized bone fiber for osteoinductivity, osteoconductivity and biolgic healing.
This is the sixth U.S. patent secured for the EnFix family of implants and their manufacturing.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
